extracellular
What it isExtracellular adenosine triphosphate acting at P2X and P2Y purinergic receptors.
Why this oneP2Y12 is the receptor clopidogrel, prasugrel and ticagrelor block, so the entire antiplatelet class is defined by it.
What limits itIts rapid degradation to adenosine means purinergic signaling shifts character within seconds of release.
NO BOXED WARNINGS
Principal riskEndogenous or dietary; no boxed warning applies
